All the following antiretrol drugs produce dyslipidemia except
**Core Concept**
Atazanavir, darunavir, and lopinavir are protease inhibitors used in the treatment of HIV/AIDS. These drugs can cause dyslipidemia, a condition characterized by abnormal levels of lipids in the blood, including high levels of triglycerides and low levels of high-density lipoprotein (HDL) cholesterol.
**Why the Correct Answer is Right**
Atazanavir, darunavir, and lopinavir are known to cause dyslipidemia due to their mechanism of action, which involves the inhibition of the protease enzyme in HIV-infected cells. This can lead to increased levels of triglycerides and decreased levels of HDL cholesterol. The dyslipidemia associated with these protease inhibitors can increase the risk of cardiovascular disease in HIV-infected individuals.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because atazanavir is known to cause dyslipidemia.
**Option B:** This option is incorrect because darunavir is also associated with dyslipidemia.
**Option C:** This option is incorrect because lopinavir causes dyslipidemia as well.
**Clinical Pearl / High-Yield Fact**
It is essential for clinicians to monitor lipid profiles in patients receiving protease inhibitors, as dyslipidemia can be a significant side effect of these medications.
**Correct Answer:** A. Atazanavir does not cause significant dyslipidemia compared to the other protease inhibitors.